Der Nephrologe

, Volume 2, Issue 3, pp 167–174

Infektionen nach Nierentransplantation

  • C. Morath
  • C. Sommerer
  • J. Schmidt
  • H. Krastel
  • V. Schwenger
  • M. Zeier
Leitthema
  • 92 Downloads

Zusammenfassung

Infektionen nach Nierentransplantation sind mit einer hohen Morbidität und Mortalität assoziiert. Deshalb sollten potenzielle Infektionsherde im Nierentransplantatempfänger schon vor Transplantation identifiziert und saniert werden, sowie notwendige Impfungen vorgenommen werden. Nach Nierentransplantation sind prophylaktische Maßnahmen zur Vermeidung von Infektionen insbesondere in den ersten Monaten einzuhalten. Dazu gehört die Gabe von Virustatika und Antibiotika, aber auch die ausführliche Aufklärung des Patienten über potenzielle Gefahren. Nach Nierentransplantation ist v. a. in der ersten Phase ein engmaschiges Monitoring des Patienten hinsichtlich Infektionen zu gewährleisten. Bei Fieber oder Anstieg der Infektparameter sollte frühzeitig eine intensive Abklärung erfolgen, der sich eine zielgerichtete antimikrobielle Therapie anschließt. Durch frühzeitige Diagnostik und Therapie lassen sich so auch schwerwiegende Infektionen größtenteils gut beherrschen.

Schlüsselwörter

Transplantation Infektionen Monitoring Antimikrobielle Therapie Prophylaxe 

Infections after renal transplantation

Abstract

Infections after renal transplantation are associated with a high morbidity and mortality. Prior to transplantation potential sources of infection should be identified and treated adequately, and important vaccinations should be performed. After renal transplantation prophylactic treatments to avoid infections are very important. These include treatment with virostatics and antibiotics as well as patients’ training concerning potential infections. Intensive monitoring of patients during the first period after transplantation is vital. Fever or increasing parameters of infection should be clarified carefully, followed by specific antimicrobial therapy. Early diagnosis and therapy may help to control life threatening infections after transplantation.

Key words

Transplantation Infections Monitoring Antimicrobial therapy Prophylaxis 

Literatur

  1. 1.
    Sayegh MH, Carpenter CB (2004) Transplantation 50 years later progress, challenges, and promises. N Engl J Med 351: 2678–2680CrossRefPubMedGoogle Scholar
  2. 2.
    Jamil B, Nicholls K, Becker GJ, Walker RG (1999) Impact of acute rejection therapy on infections and malignancies in renal transplant recipients. Transplantation 68: 1597–1619CrossRefPubMedGoogle Scholar
  3. 3.
    Alangaden GJ, Thyagarajan R, Gruber SA et al. (2006) Infectious complications after kidney transplantation: current epidemiology and associated risk factors. Clin Transplant 20: 401–409CrossRefPubMedGoogle Scholar
  4. 4.
    Kuse ER, Langfeld I, Jaeger K, Kulpmann WR (2000) Procalcitonin in fever of unknown origin after transplantation: a variable to differentiate acute rejection from infection. Crit Care Med 28: 555–559CrossRefPubMedGoogle Scholar
  5. 5.
    Hammer S, Meisner F, Dirschedl P et al. (1998) Procalcitonin a new marker for diagnosis of acute rejection and bacterial infection in patients after heart and lung transplantation. Transplant Immunol 6: 235–241CrossRefGoogle Scholar
  6. 6.
    Fishman JA, Rubin RH (1998) Infection in organ transplant recipients. N Engl J Med 338: 1741–1751CrossRefPubMedGoogle Scholar
  7. 7.
    Rao VK (1998) Posttransplant medical complications. Surg Clin North Amer 78: 113–132CrossRefGoogle Scholar
  8. 8.
    Kallinowski B, Hergesell O, Zeier M (2002) Clinical impact of hepatitis C virus infection in the renal transplant recipient. Nephron 91: 541–546CrossRefPubMedGoogle Scholar
  9. 9.
    Schmaldienst S, Hörl WH (1997) Bacterial infections after renal transplantation. Nephron 75: 140–153PubMedGoogle Scholar
  10. 10.
    Srmiento JM, Docrell DH, Schwab TR et al. (2000) Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients. Clin Transplant 14: 136–138CrossRefPubMedGoogle Scholar
  11. 11.
    Wienecke H, Otte B, Lang D, Heidenreich S (1996) Predictive value of IgG subclass levels for infectious complications in renal transplant recipients. Clin Nephrol 45: 22–28PubMedGoogle Scholar
  12. 12.
    Martins C, Pecoits-Filho R, Riella M (2004) Nutrition for the post-renal transplant recipients. Transplant Proc 36: 1650–1654CrossRefPubMedGoogle Scholar
  13. 13.
    Fabrizi F, Martin P, Dixit V et al. (2005) Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies. Am J Transplant 5: 2433–2440CrossRefPubMedGoogle Scholar
  14. 14.
    Hergesell O, Zeier M (2003) Underdiagnosis for diabetes mellitus in chronic dialysis patients on the renal transplant waiting list. Transplant Proc 35: 1287–1289CrossRefPubMedGoogle Scholar
  15. 15.
    Zeier M, Ritz E (2002) Preparation of the dialysis patient for transplantation. Nephrol Dial Transplant 17: 552–556CrossRefPubMedGoogle Scholar
  16. 16.
    Prelog M, Pohl M, Ermisch B et al. (2007) Demand for evaluation of vaccination antibody titers in children considered for renal transplantation. Pediatr Transplant 11: 73–76CrossRefPubMedGoogle Scholar
  17. 17.
    Geel AL, Landman TS, Kal JA et al. (2006) Varicella zoster virus serostatus before and after kidney transplantation, and vaccination of adult kidney transplant candidates. Transplant Proc 38: 3418–3419CrossRefPubMedGoogle Scholar
  18. 18.
    Fehrenbach FJ, Müller HJ, Ruf R, Seidel K (1989) Die Legionärskrankheit. Dtsch Arztebl 86: B830–B833Google Scholar
  19. 19.
    Rubin RH (1993) Infectious complications of renal transplantation. Kidney Internat 44: 221–236Google Scholar
  20. 20.
    Midtvedt K, Hartmann A, Midtvedt T, Brelcke IR (1998) Routine perioperative antibiotic prophylaxis in renal transplantation. Nephrol Dial Transplant 13: 1637–1641CrossRefPubMedGoogle Scholar
  21. 21.
    Schwenger V, Mundlein E, Dagrosa EE et al. (2002) Treatment of life-threatening multiresistant staphylococcal and enterococcal infections in patients with end-stage renal failure with quinupristin/dalfopristin: preliminary report. Infection 30: 257–261CrossRefPubMedGoogle Scholar
  22. 22.
    Jassal SV, Roscoe JM, Zaltzman JM et al. (1998) Clinical practice guidelines: prevention of cytomegalovirus disease after renal transplantation. J Am Soc Nephrol 9: 1697–1708PubMedGoogle Scholar
  23. 23.
    Beockh M, Gooley TA, Myerson T et al. (1996) Cytomegalovirus pp65 antigenaemia-guided early treatment with ganciclovir versus gangciclovir at engraftment after allogeneic bone marrow transplantation; a randomized double-blind study. Blood 88: 4063–4071PubMedGoogle Scholar
  24. 24.
    Lowance D, Neumayer HH, Legendre CM et al. (1999) Valaciclovir for the prevention of cytomegalovirus disease after renal transplantation. N Engl J Med 340: 1462–1470CrossRefPubMedGoogle Scholar
  25. 25.
    Preiksaitis JK, Dias-Mitoma F, Mirzayans F et al. (1992) Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serological responses, and the risk of post-transplant lymphoproliferative disorder. J Infect Dis 152: 876–886Google Scholar
  26. 26.
    Domhan S, Morath C, Schnulle P et al. (2005) A generalized seizure in a renal allograft recipient. Nephrol Dial Transplant 20: 834–836CrossRefPubMedGoogle Scholar
  27. 27.
    Wang FZ, Linde A, Hagglund H et al. (1999) Human herpes-virus 6 DNA in cerebrospinal fluid specimens from allogenic bone marrow transplant patients: does it have clinical significance? Clin Infect Dis 28: 562–568PubMedGoogle Scholar
  28. 28.
    Williams JW, Jawaid B, Kadambi PV et al. (2005) Leflunomide for polyomavirus type BK nephrophathy. N Engl J Med 352: 1157–1158CrossRefPubMedGoogle Scholar
  29. 29.
    Kuypers DR, Vandooren AK, Lerut E et al. (2005) Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant 5: 1997–2004CrossRefPubMedGoogle Scholar
  30. 30.
    Almyroudis NG, Sutton DA, Linden P et al. (2006) Zygomycosis in solid organ transplant recipients in a teritiary transplant center and review of the literature. Am J Transplant 10: 2365–2374CrossRefGoogle Scholar
  31. 31.
    Braddy CM, Heilman RL, Blair JE (2006) Coccidioidomycosis after renal transplantation in an endemic area. Am J Transplant 2: 340–345CrossRefGoogle Scholar
  32. 32.
    Wulf MW, Crevel R van, Portier R et al. (2005) Toxoplasmosis after renal transplantation: implications of a missed diagnosis. J Clin Microbiol 43: 3544–3547CrossRefPubMedGoogle Scholar
  33. 33.
    Grindt M and Köhler H (2005) Impfempfehlungen für Patienten nach Nierentransplantation. Mitt Klein Nephrologie XXXIVGoogle Scholar

Copyright information

© Springer Medizin Verlag 2007

Authors and Affiliations

  • C. Morath
    • 1
  • C. Sommerer
    • 1
  • J. Schmidt
    • 2
  • H. Krastel
    • 3
  • V. Schwenger
    • 1
  • M. Zeier
    • 1
  1. 1.Sektion NephrologieMedizinische KlinikHeidelbergDeutschland
  2. 2.TransplantationszentrumChirurgische Universitätsklinik HeidelbergHeidelbergDeutschland
  3. 3.Universitäts-Augenklinik HeidelbergHeidelbergDeutschland

Personalised recommendations